Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3

Journal of Medicinal Chemistry

Volumn 52, Issue 19, 2009, Pages 6126-6141

  Mandal, Pijus K ^a   Ren, Zhiyong ^a   Chen, Xiaomin ^a   Xiong, Chiyi ^a   McMurray, John S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 5 BENZYLOXYHEXANAMIDE; 4 AMINOBUTYRAMIDE; AMIDE; GLUTAMINE; PHOSPHOPEPTIDE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; PEPTIDE SYNTHESIS; PROTEIN BINDING; PROTEIN DOMAIN; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 70349651657     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm901105k     Document Type: Article

References (44)

1. Levy, D. E.; Darnell, J. E., Jr. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 2002, 3, 651-662.
2. Darnell, J. E., Jr. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer 2002, 2, 740-749.
3. Bromberg, J.; Darnell, J. E., Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19, 2468-2473.
4. Yu, H.; Jove, R. The STATs of cancer;new molecular targets come of age. Nat. Rev. Cancer 2004, 4, 97-105.
5. Cirillo, D.; Rachiglio, A. M.; la Montagna, R.; Giordano, A.; Normanno, N. Leptin signaling in breast cancer: an overview. J. Cell. Biochem. 2008, 105, 956-964.
6. Bowman, T.; Garcia, R.; Turkson, J.; Jove, R. STATs in oncogenesis. Oncogene 2000, 19, 2474-2488.
7. Ren, Z.; Cabell, L. A.; Schaefer, T. S.; McMurray, J. S. Identification of a high-affinity phosphopeptide inhibitor of Stat3. Bioorg. Med. Chem. Lett. 2003, 13, 633-636.
8. Coleman, D. R.; Ren, Z.; Mandal, P. K.; Cameron, A. G.; Dyer, G. A.; Muranjan, S.; Campbell, M.; Chen, X.; McMurray, J. S. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor. J. Med. Chem. 2005, 48, 6661-6670.
9. Coleman, D. R., IV; Kaluarachchi, K.; Ren, Z.; Chen, X.; McMurray, J. S. Solid phase synthesis of phosphopeptides incorporating 2,2-dimethyloxazolidine pseudoproline analogs: evidence for trans Leu-Pro peptide bonds in Stat3 inhibitors. Int. J. Pept. Res. Ther. 2008, 14, 1-9.
10. Mandal, P. K.; Heard, P. A.; Ren, Z.; Chen, X.; McMurray, J. S. Solid-phase synthesis of Stat3 inhibitors incorporating O-carbamoylserine and O-carbamoylthreonine as glutamine mimics. Bioorg. Med. Chem. Lett. 2007, 17, 654-656.
11. Mandal, P. K.; Limbrick, D.; Coleman, D. R.; Dyer, G. A.; Ren, Z.; Birtwistle, J. S.; Xiong, C.; Chen, X.; Briggs, J. M.; McMurray, J. S. Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription 3: evaluation and molecular modeling. J. Med. Chem. 2009, 52, 2429-2442.
12. Turkson, J.; Ryan, D.; Kim, J. S.; Zhang, Y.; Chen, Z.; Haura, E.; Laudano, A.; Sebti, S.; Hamilton, A. D.; Jove, R. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J. Biol. Chem. 2001, 276, 45443-45455.
13. Turkson, J.; Kim, J. S.; Zhang, S.; Yuan, J.; Huang, M.; Glenn, M.; Haura, E.; Sebti, S.; Hamilton, A. D.; Jove, R. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol. Cancer Ther. 2004, 3, 261-269.
14. Siddiquee, K. A.; Gunning, P. T.; Glenn, M.; Katt, W. P.; Zhang, S.; Schrock, C.; Sebti, S. M.; Jove, R.; Hamilton, A. D.; Turkson, J. An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. ACS Chem. Biol. 2007, 2, 787-798.
15. Gunning, P. T.; Katt, W. P.; Glenn, M.; Siddiquee, K.; Kim, J. S.; Jove, R.; Sebti, S. M.; Turkson, J.; Hamilton, A. D. Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains. Bioorg. Med. Chem. Lett. 2007, 17, 1875-1878.
16. Gunning, P. T.; Glenn, M. P.; Siddiquee, K. A.; Katt, W. P.; Masson, E.; Sebti, S. M.; Turkson, J.; Hamilton, A. D. Targeting protein-protein interactions: suppression of Stat3 dimerization with rationally designed small-molecule, nonpeptidic SH2 domain binders. ChemBioChem 2008, 9, 2800-2803.
17. Shao, H.; Cheng, H. Y.; Cook, R. G.; Tweardy, D. J. Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res. 2003, 63, 3923-3930.
18. Shao, H.; Xu, X.; Mastrangelo, M. A.; Jing, N.; Cook, R. G.; Legge, G. B.; Tweardy, D. J. Structural requirements for signal transducer and activator of transcription 3 binding to phosphotyrosine ligands containing the YXXQ motif. J. Biol. Chem. 2004, 279, 18967-18973.
19. Dourlat, J.; Valentin, B.; Liu, W. Q.; Garbay, C. New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors. Bioorg. Med. Chem. Lett. 2007, 17, 3943-3946.
20. Chen, J.; Nikolovska-Coleska, Z.; Yang, C. Y.; Gomez, C.; Gao, W.; Krajewski, K.; Jiang, S.; Roller, P.; Wang, S. Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via "click chemistry". Bioorg. Med. Chem. Lett. 2007, 17, 3939-3942.
21. Gomez, C.; Bai, L.; Zhang, J.; Nikolovska-Coleska, Z.; Chen, J.; Yi, H.; Wang, S. Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitors. Bioorg. Med. Chem. Lett. 2009, 19, 1733-1736.
22. Stahl, N.; Farruggella, T. J.; Boulton, T. G.; Zhong, Z.; Darnell, J. E., Jr.; Yancopoulos, G. D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995, 267, 1349-1353.
23. Gerhartz, C.; Heesel, B.; Sasse, J.; Hemmann, U.; Landgraf, C.; Schneider-Mergener, J.; Horn, F.; Heinrich, P. C.; Graeve, L. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. J. Biol. Chem. 1996, 271, 12991-12998.
24. Wiederkehr-Adam, M.; Ernst, P.; Muller, K.; Bieck, E.; Gombert, F. O.; Ottl, J.; Graff, P.; Grossmuller, F.; Heim, M. H. Characterization of phosphopeptide motifs specific for the Src homology 2 domains of signal transducer and activator of transcription 1 (STAT1) and STAT3. J. Biol. Chem. 2003, 278, 16117-16128.
25. Sawyer, T. K. Src homology-2 domains: structure, mechanisms, and drug discovery. Biopolymers 1998, 47, 243-261. (Pubitemid 128570208)
26. Muller, G. Peptidomimetic SH2 domain antagonists for targeting signal transduction. Top. Curr. Chem. 2001, 211, 17-59.
27. Shakespeare, W. C. SH2 domain inhibition: a problem solved? Curr. Opin. Chem. Biol. 2001, 5, 409-415.
28. Garcia-Echeverria, C. Antagonists of the homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70. Curr. Med. Chem. 2001, 8, 1589-1604.
29. Metcalf, C. A., III; Sawyer, T. Src homology-2 domains and structure-based, small-molecule library approaches to drug discovery. In Drug Discovery Strategies and Methods; Makriyannis, A., Biegel, D., Eds.; Marcel Dekker: New York, 2004; pp 23-59.
30. Garcia-Echeverria, C. Inhibitors of signaling interfaces: targeting Src homology 2 domains in drug discovery. Protein Tyrosine Kinases 2006, 31-52.
31. McMurray, J. S. Structural basis for the binding of high affinity phosphopeptides to Stat3. Biopolymers 2008, 90, 69-79.
32. A preliminary account of the syntheses of 63c-h and 64c-h was presented at the 20th American Peptide Symposium, June 2007. Mandal, P. K.; McMurray, J. S. Application of triethylsilane and palladium-charcoal-induced reductions in the synthesis of Fmoc-glutamic acid analogues. Adv. Exp. Med. Biol. 2009, 611, 181-182.
33. Pearson, D. A.; Blanchette, M.; Baker, M. L.; Guindon, C. A. Trialkylsilanes as scavengers for the trifluoroacetic acid deblocking of protecting groups in peptide synthesis. Tetrahedron Lett. 1989, 30, 2739-2742.
34. Mazurov, A. Solid phase synthesis of 5,6,7,8-tetrahydro - 1H-imidazo[4,5-g]quinoxalin-6-ones. Tetrahedron Lett. 2000, 41, 7-10.
35. Wen, J. J.; Crews, C. M. Synthesis of 9-fluorenylmethoxycarbonylprotected amino aldehydes. Tetrahedron: Asymmetry 1998, 9, 1855-1858.
36. Ahern, D. G.; Lassiter, A. G.; Filer, C. N. Animproved synthesis of 4-aminotetrolic acid. Synth. Commun. 2002, 32, 665-667.
37. Humljan, J.; Gobec, S. Synthesis of N-phthalimido [beta]- aminoethanesulfonyl chlorides: the use of thionyl chloride for a simple and efficient synthesis of new peptidosulfonamide building blocks. Tetrahedron Lett. 2005, 46, 4069-4072.
38. Mandal, P. K.; McMurray, J. S. Pd-C-induced catalytic transfer hydrogenation with triethylsilane. J. Org. Chem. 2007, 72, 6599-6601.
39. Loukas, V.; Noula, C.; Kokotos, G. Efficient protocols for the synthesis of enantiopure gamma-amino acids with proteinogenic side chains. J. Pept. Sci. 2003, 9, 312-319.
40. Mondal, S.; Fan, E. Mild and efficient synthesis of Fmoc-protected amino azides from Fmoc-protected amino alcohols. Synlett 2006, 306-308. (Pubitemid 43221322)
41. Kates, S. A.; De La Torre, B. G.; Eritja, R.; Albericio, F. Solid-phase N-glycopeptide synthesis using allyl side-chain protected Fmoc-amino acids. Tetrahedron Lett. 1994, 35, 1033-1034. (Pubitemid 24084855)
42. Boeijen, A.; van Ameijde, J.; Liskamp, R. M. Solid-phase synthesis of oligourea peptidomimetics employing the Fmoc protection strategy. J. Org. Chem. 2001, 66, 8454-8462.
43. Debaene, F.; Da Silva, J. A.; Pianowski, Z.; Duran, F. J.; Winssinger, N. Expanding the scope of PNA-encoded libraries: divergent synthesis of libraries targeting cysteine, serine and metallo-proteases as well as tyrosine phosphatases. Tetrahedron 2007, 63, 6577-6586. (Pubitemid 46817614)
44. Jobron, L.; Hummel, G. Solid-phase synthesis of new S-glycoamino acid building blocks. Org. Lett. 2000, 2, 2265-2267.